Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 21-30 of 84

Page
per page
  1. Concanamycin A
    A8633 Concanamycin A
     1 Citation
    Target: Vacuolar-type ATPase
    Summary: V-type (vacuolar) H+-ATPase inhibitor
      soluble in DMSO
  2. MNS
    A8661 MNS
    Summary: Inhibitor of Src/Syk tyrosine kinases
  3. NSC697923
    A8813 NSC697923
    Target: Ub-conjugating enzyme (E2) complex
    Summary: Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective
      insoluble in H2O; insoluble in EtOH; ≥26 mg/mL
  4. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: inhibitor of Ubiquitin-Activating Enzyme (E1)
  5. NMS-873
    B2168 NMS-873
     3 Citation
    Target: Valosin-containing protein (VCP)
    Summary: VCP/p97 inhibitor,selective and allosteric
      insoluble in H2O; ≥17.1 mg/mL
  6. SJB2-043
    A3823 SJB2-043
    Target: USP
    Summary: USP1 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.62 mg/mL
  7. ML-323
    B1317 ML-323
    Target: Deubiquitinating enzymes (DUBs)
    Summary: USP1-UAF1 inhibitor
  8. SJB3-019A
    B1307 SJB3-019A
    Target: USP
    Summary: Usp1 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.85 mg/mL
  9. Trifluoperazine 2HCl
    B1397 Trifluoperazine 2HCl
    Summary: Dopamine D2 receptor inhibitor
      ≥24.02 mg/mL
  10. Sulfacetamide Sodium
    B1395 Sulfacetamide Sodium
    Summary: Sulfonamide antibiotic
      ≥10.65 mg/mL

Items 21-30 of 84

Page
per page